<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30097">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01892917</url>
  </required_header>
  <id_info>
    <org_study_id>G1217</org_study_id>
    <nct_id>NCT01892917</nct_id>
  </id_info>
  <brief_title>BIOFLOW-III Hungary Satellite Registry</brief_title>
  <official_title>BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Hungary</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik Hungária Kft.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik Hungária Kft.</source>
  <oversight_info>
    <authority>Hungary: Scientific and Medical Research Council Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring
      coronary revascularization with Drug Eluting Stents (DES)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the majority of Coronary Artery Disease (CAD), treatment with Percutaneous Transluminal
      Coronary Angioplasty (PTCA) provides high initial procedural success. However, the medium to
      long-term complications range from rather immediate elastic recoil or vessel contraction to
      longer processes like smooth muscle cell proliferation and excessive production of extra
      cellular matrix, thrombus formation and atherosclerotic changes like restenosis or
      angiographic re-narrowing. The reported incidence of restenosis after PTCA ranges from
      30%-50%. Such rates of recurrence have serious economic consequences. Bare Metal Stents
      (BMS), designed to address the limitations of PTCA, reduced the angiographic and clinical
      restenosis rates in de novo lesions compared to PTCA alone and decreased the need for CABG.
      BMS substantially reduced the incidence of abrupt artery closure, but restenosis still
      occurred in about 20%-40% of cases, necessitating repeat procedures. The invention of Drug
      Eluting Stents (DES) significantly improved on the principle of BMS by adding an
      antiproliferative drug (directly immobilised on the stent surface or released from a polymer
      matrix), which inhibits neointimal hyperplasia. The introduction of DES greatly reduced the
      incidence of restenosis and resulted in a better safety profile as compared to BMS with
      systemic drug administration. These advantages and a lower cost compared to surgical
      interventions has made DES an attractive option to treat coronary artery disease. This
      observational registry is designed to investigate and collect clinical evidence for the
      clinical performance and safety of the Orsiro Drug Eluting Stent System in an all-comers
      patient population in daily clinical practice
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Target Lesion Failure (TLF)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Composite of cardiac death, target vessel Q-wave or non-Q wave Myocardial Infarction (MI), Emergent Coronary Artery Bypass Graft (CABG), clinically driven Target Lesion Revascularization (TLR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Failure</measure>
    <time_frame>6 and 18 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel Revascularization (TVR)</measure>
    <time_frame>6, 12 and 18 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any repeat revascularization of the target vessel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Revascularization (TLR)</measure>
    <time_frame>6, 12 and 18 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any repeat revascularization of the target lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis</measure>
    <time_frame>6, 12 and 18 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Device Success</measure>
    <time_frame>At time of intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Procedural Success</measure>
    <time_frame>During the hospital stay to a maximum of the first seven days post index procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All-comers patient population with all subjects requiring coronary revascularization with
        a Drug Eluting Stent (DES)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic coronary artery disease

          -  Subject has signed informed consent for data release

          -  Subject is geographically stable and willing to participate at all follow-up
             assessments

          -  Subject is ≥ 18 years

        Exclusion Criteria:

          -  Subject did not sign informed consent for data release

          -  Pregnancy - Known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any
             other anticoagulation / antiplatelet therapy required for PCI, stainless steel,
             Sirolimus or contrast media

          -  Planned surgery within 6 months of PCI unless dual antiplatelet therapy will be
             maintained

          -  Currently participating in another study and primary endpoint is not reached yet
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Béla Merkely, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eszter Liptay</last_name>
    <phone>+ 36-1-326-4941</phone>
    <email>eszter.liptay@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Állami Szívkórház (State Hospital for cardiology of Balatonfüred)</name>
      <address>
        <city>Balatonfüred</city>
        <zip>8231</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faluközi József, Dr</last_name>
      <phone>+36 87 584 580</phone>
      <email>falukozy@elso.bfkor.hu</email>
    </contact>
    <investigator>
      <last_name>Faluközi József</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SE ÁOK Kardiológiai Központ (Semmelweis University, Heart Center)</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merkely Béla, Prof Dr</last_name>
      <phone>+36 1 458 6840</phone>
      <email>titkarsag@kardio.sote.hu</email>
    </contact>
    <contact_backup>
      <last_name>Szabó György, Dr</last_name>
      <phone>+36 1 458 6840</phone>
      <email>szabogeorgester@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Merkely Béla, Prof Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Magyar Honvédség Honvédkórház, Kardiológiai Osztály (Medical Centre, Hungarian Defence Forces, Cardiology Department)</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gottsegen György Országos Kardiológiai Intézet (Gottsegen György Hungarian Institute of Cardiology)</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fontos Géza, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Fontos Géza, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Budai Irgalmasrendi Kórház (Budai Irgalmasrendi Hospital)</name>
      <address>
        <city>Budapest</city>
        <zip>1027</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zsoldos András, Dr</last_name>
      <phone>+36-1-438-8400</phone>
      <email>andraszsoldos@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Zsoldos András, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bajcsy-Zsilinszky Kórház (Bajcsy-Zsilinszky Hospital)</name>
      <address>
        <city>Budapest</city>
        <zip>1106</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nagybaczoni Béla, Dr</last_name>
      <phone>+ 36 1 432-9545</phone>
      <email>bacom@t-online.hu</email>
    </contact>
    <investigator>
      <last_name>Nagybaczoni Béla, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DEOEC, Kardiológiai Intézet ( Institute of Cardiology, University of Debrecen)</name>
      <address>
        <city>Debrecen</city>
        <zip>4012</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vajda Gusztáv, Dr</last_name>
      <phone>+36 52 255-928</phone>
      <email>info@debkard.hu</email>
    </contact>
    <investigator>
      <last_name>Vajda Gusztáv, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Petz Aladár Megyei Oktató Kórház, 9024 (Petz Aladár Teaching Hospital)</name>
      <address>
        <city>Győr</city>
        <zip>9024</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dézsi Csaba, Dr</last_name>
      <phone>+36 96 418 244</phone>
      <phone_ext>1817</phone_ext>
      <email>dcsa@petz.gyor.hu</email>
    </contact>
    <investigator>
      <last_name>Dézsi Csaba, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaposi Mór Oktató Kórház, Kardiológia (Kaposi Mór Teaching Hospital, Cardiology)</name>
      <address>
        <city>Kaposvár</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Papp Előd, Dr</last_name>
      <phone>+36-82-801-813</phone>
      <email>pappelod@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Papp Előd, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bács-Kiskun Megyei Önkormányzat Kórháza, Kardiológia (Hospital of Bács-Kiskun County Council, Cardiology)</name>
      <address>
        <city>Kecskemét</city>
        <zip>6000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruzsa Zoltán, Dr</last_name>
      <phone>+ 36 76 516-700</phone>
      <email>zruzsa25@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ruzsa Zoltán, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Borsod-Abaúj-Zemplén Megyei Kórház, Kardiológia (Borsod-Abaúj-Zemplén County Hospital, Cardiology)</name>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ondrejkó Zsolt, Dr</last_name>
      <phone>+ 36 46 515-200</phone>
      <email>korhig@bazmkorhaz.hu</email>
    </contact>
    <investigator>
      <last_name>Ondrejkó Zsolt, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jósa András Kórház, Kardiológia (Jósa András Hospital, Department of Cardiology)</name>
      <address>
        <city>Nyíregyháza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kőszegi Zsolt, Dr</last_name>
      <phone>+36 42 599-700</phone>
      <email>koszegi@jaguar.dote.hu</email>
    </contact>
    <investigator>
      <last_name>Kőszegi Zsolt, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PTE ÁOK Szívcentrum (University of Pécs, Faculty of Medicine, Heart Institute)</name>
      <address>
        <city>Pécs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horváth Iván Docens, Dr</last_name>
      <phone>+ 36 72 536000</phone>
      <email>ivan.g.horvath@aok.pte.hu</email>
    </contact>
    <investigator>
      <last_name>Horváth Iván Docens, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szentgyörgyi Albert Tudomány Egyetem, ÁOK, Kardiológia (University of Szeged, Albert Szent-Györgyi Clinical Center, Faculty Of Medicine, Second Department of Medicine and Cardiology Centre)</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ungi Imre, Dr</last_name>
      <phone>+36 62 546-492</phone>
      <email>imre@tipomed.hu</email>
    </contact>
    <investigator>
      <last_name>Ungi Imre, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház, Kardiológia-Hemodinamika (Jász-Nagykun-Szolnok County, Hetényi Géza Hospital, Cardiology, Haemodynamics)</name>
      <address>
        <city>Szolnok</city>
        <zip>5004</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Szabó György, Dr.</last_name>
      <phone>+ 36 56 503 603</phone>
      <email>szabogeorgester@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Szabó György, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vas Megyei Markusovszky Kórház Zrt (Vas County, Markusovszky Hospital)</name>
      <address>
        <city>Szombathely</city>
        <zip>9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nagy Lajos, Prof Dr</last_name>
      <phone>+ 36 94 311 542</phone>
      <email>nagy.lajos@markusovszky.hu</email>
    </contact>
    <investigator>
      <last_name>Nagy Lajos, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fejér Megyei Szent György Kórház (Fejér County Szent György Hospital)</name>
      <address>
        <city>Székesfehérvár</city>
        <zip>8001</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bokori György, Dr</last_name>
      <phone>+ 36 20-944-9161</phone>
      <email>gy.bokori@freemail.hu</email>
    </contact>
    <investigator>
      <last_name>Bokori György, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zala Megyei Kórház, Kardiológia (Zala County Hospital, Cardiology)</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lupkovics Géza, Dr</last_name>
      <phone>+36 92 507 500</phone>
      <phone_ext>1240</phone_ext>
      <email>zalahemo@zalaszam.hu</email>
    </contact>
    <investigator>
      <last_name>Lupkovics Géza, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>July 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>International</keyword>
  <keyword>Multicenter</keyword>
  <keyword>Observational registry</keyword>
  <keyword>Orsiro Drug Eluting Stent (DES)</keyword>
  <keyword>Stenting</keyword>
  <keyword>Treatment of Coronary Artery Disease</keyword>
  <keyword>Coronary revascularization</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>STEMI</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Subgroups</keyword>
  <keyword>Acute Myocardial Infarction</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Small Vessels</keyword>
  <keyword>Chronic Total Occlusion (CTO)</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
